Compound 1243
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1cccc(CN(Cc2ccc(cc2)-c2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1ccc2[nH]c(=O)c(=O)[nH]c2c1
- InChi:
InChI=1S/C40H35Cl2FN4O6S/c1-24(2)20-46(40(51)30-12-15-34-35(17-30)45-39(50)38(49)44-34)21-26-4-3-5-27(16-26)23-47(54(52,53)36-19-31(41)18-33(42)37(36)48)22-25-6-8-28(9-7-25)29-10-13-32(43)14-11-29/h3-19,24,48H,20-23H2,1-2H3,(H,44,49)(H,45,50)
- InChiKey:
ZDGCUWGHRIHVNS-UHFFFAOYSA-N
External links
![]() 66616502 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 190 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.74 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 788.16 g/mol | |||
HBA | 10 | |||
HBD | 3 | |||
HBA + HBD | 13 | |||
AlogP | 8.10 | |||
TPSA | 136.12 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 190 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.74 | |
WO2009152082 | 190 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.26 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4495 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4402 | 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE | DB04608 | |
0.4381 | CGS-27023 | DB07556 | |
0.4356 | GSK-364735 | DB13119 | |
0.4317 | Vidupiprant | DB12272 | |
0.4286 | Evatanepag | DB12022 | |
0.4231 | N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide | DB03596 | |
0.4204 | 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide | DB07162 | |
0.4182 | Sulfabenzamide | DB09355 | |
0.4179 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DB07265 | |
0.4142 | CX516 | DB06247 | |
0.4140 | 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione | DB07257 | |
0.4121 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4100 | Zafirlukast | DB00549 | |
0.4099 | WAY-151693 | DB02071 |